Follow
Furkan Ceylan
Furkan Ceylan
Hacettepe Üniversitesi İç Hastalıkları
Verified email at hacettepe.edu.tr
Title
Cited by
Cited by
Year
Evaluation of cancer risk in patients with periodontal diseases
DC Güven, Ö Dizdar, AC Akman, AE BERKER, E Yekedüz, F Ceylan, ...
Turkish journal of medical sciences 49 (3), 826-831, 2019
592019
Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy
DC Guven, MS Aksun, TK Sahin, OH Aktepe, HC Yildirim, H Taban, ...
Supportive Care in Cancer 29, 5417-5423, 2021
212021
The association between antibiotic use and survival in renal cell carcinoma patients treated with immunotherapy: a multi-center study
DC Guven, R Acar, E Yekeduz, I Bilgetekin, NK Baytemur, C Erol, ...
Current Problems in Cancer 45 (6), 100760, 2021
162021
Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience
E Bilgin, F Ceylan, E Duran, B Farisoğullari, EÇ Bölek, GK Yardimci, ...
Turkish Journal of Medical Sciences 51 (1), 297-308, 2021
152021
Evaluation of early unplanned readmissions and predisposing factors in an oncology clinic
DC Guven, F Ceylan, IY Cakir, E Cesmeci, B Sayinalp, B Yesilyurt, ...
Supportive Care in Cancer 29, 4159-4164, 2021
72021
Chemoimmunotherapy for the salvage treatment of Ewing sarcoma: A case report
DC Guven, S Kilickap, HC Yildirim, F Ceylan, O Bas, O Dizdar
Journal of Oncology Pharmacy Practice 27 (5), 1281-1283, 2021
62021
Knowledge, Attitudes, and Perception towards COVID-19 Vaccination among the Adult Population: A Cross-Sectional Study in Turkey. Vaccines. 2022; 10 (2): 278
MC Sonmezer, TK Sahin, E Erul, FS Ceylan, MY Hamurcu, N Morova, ...
PubMed Abstract| Publisher Full Text| Free Full Text| Reference Source, 0
5
The prognostic and predictive role of class III β-Tubulin and hENT1 expression in patients with advanced pancreatic ductal adenocarcinoma
TK Sahin, A Isik, DC Guven, F Ceylan, B Babaoglu, A Akyol, S Yalcin, ...
Pancreatology, 2024
12024
High 30-day readmission rates in hospitalized patients with heart failure: Strengthening the need for a multidisciplinary and integrated approach
H BÖLEK, S Cetik, F Ceylan, E BÖLEK, O UYAROĞLU, M TANRIÖVER
Acta Medica 54 (2), 2023
12023
A current comprehensive role of immune-checkpoint inhibitors in resectable non-small cell lung cancer: A narrative review
SC Efil, B Bilgin, F Ceylan, H Karakaş, İ Karahan, SN Özsan, H Kosku, ...
Journal of Oncology Pharmacy Practice, 10781552241260864, 2024
2024
Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy
TK Sahin, Y Ozbay, AY Altunbulak, HI Altunbulak, MR Onur, F Ceylan, ...
International Journal of Clinical Oncology 29 (6), 822-831, 2024
2024
Is fibroblast growth factor 11 (FGF11) a predictive marker for breast cancer?
SA Esen, S Karabulut, M Buyukaksoy, GK Cevik, F Ceylan, B Civelek, ...
Medicine 103 (13), e37656, 2024
2024
Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study
S Sekmek, I Karahan, G Ucar, F Ceylan, D Bayram, I Seven, H Bölek, ...
Clinical and Translational Oncology, 1-8, 2024
2024
Erken Evre ve Yaygın Evre Küçük Hücreli Akciğer Kanserinde Güncel Tedavi Yaklaşımları
F CEYLAN, MAN ŞENDUR
Turkiye Klinikleri Medical Oncology-Special Topics 17 (2), 74-84, 2024
2024
Role of Immunotherapy for Small Cell Lung Cancer
F CEYLAN, MAN ŞENDUR
Turkiye Klinikleri Medical Oncology-Special Topics 17 (1), 44-51, 2024
2024
1638P The prognostic and predictive role of class III β-tubulin and hENT1 expression in patients with advanced pancreatic ductal adenocarcinoma
TK Sahin, A Isik, DC Guven, F Ceylan, B Babaoglu, A Akyol, S Yalcin, ...
Annals of Oncology 34, S906, 2023
2023
1608P Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy
O Dizdar, TK Sahin, Y Ozbay, AY Altunbulak, Hİ Altunbulak, MR Onur, ...
Annals of Oncology 34, S890-S891, 2023
2023
Prognostic and predictive value of tumoral DNA damage repair protein expression in patients with resected pancreatic cancer
F Ceylan, DC Guven, H Taban, O Aktepe, TK Sahin, S Kilickap, A Turker, ...
Clinics and Research in Hepatology and Gastroenterology 47 (3), 102091, 2023
2023
Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience
Ö Karadağ, E Bilgin, F Ceylan, E Duran, B Farisoğullari, EÇ Bölek, ...
Turkish Journal of Medical Sciences, 2021
2021
İleri Evre Panreatiko Biliyer Sistem Tümörlerinde Tedavi
ÖD Hakan TABAN, Burak Yasin AKTAŞ, Furkan CEYLAN
Türkiye Klinikleri 14 (1), p.84- 91., 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20